Felix Biotechnology: Funding, Investors & Team (Sep 2026)
Felix Biotechnology is attempting to speed up the arrangement of novel biotherapeutics to oversee irresistible illnesses. Felix Biotechnology's profile therapeutics targets anti-toxin safe microscopic organisms to oversee irresistible sicknesses exactly and really, permitting medical care experts to oversee pressing microbial difficulties in human wellbeing.
Felix Biotechnology has raised $410k across 2 funding rounds on record, the most recent a Grant of $310k announced in Jul 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Felix Biotechnology Company Profile and Key Stats
Latest funding round on record: Jul 2022.
Felix Biotechnology Funding Rounds
Felix Biotechnology raised $100k in a Grant announced in Mar 2022.
4 months later, a Grant of $310k was announced in Jul 2022.
Felix Biotechnology Founders and Leadership Team
No contact details are on record for this team yet.
Felix Biotechnology Funding Compared to Other Biotechnology Startups
Felix Biotechnology's latest round of $310k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Felix Biotechnology in Biotechnology and San Francisco
Companies Similar to Felix Biotechnology
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Felix Biotechnology Funding FAQs
What does Felix Biotechnology do?
Felix Biotechnology is attempting to speed up the arrangement of novel biotherapeutics to oversee irresistible illnesses. Felix Biotechnology's profile therapeutics targets anti-toxin safe microscopic organisms to oversee irresistible sicknesses exactly and really, permitting medical care experts to oversee pressing microbial difficulties in human wellbeing.
How much funding has Felix Biotechnology raised?
Felix Biotechnology has raised $410k across 2 rounds on record. The most recent is a Grant of $310k announced in Jul 2022.
When did Felix Biotechnology last raise funding?
Felix Biotechnology's most recent funding round on record is a Grant of $310k, announced in Jul 2022.
Who founded Felix Biotechnology?
FundedIQ lists Paul Turner (Founder) at Felix Biotechnology.
Who is the CEO of Felix Biotechnology?
Robert McBride is listed as CEO at Felix Biotechnology.
Where is Felix Biotechnology headquartered?
Felix Biotechnology is based in San Francisco, California, United States.
How many employees does Felix Biotechnology have?
Felix Biotechnology is in the 1-10 employee band.
How does Felix Biotechnology's funding compare to other Biotechnology startups?
Felix Biotechnology's latest round of $310k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Felix Biotechnology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Felix Biotechnology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.